BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17109289)

  • 1. Influenza will not miss opportunities.
    Kaiser L
    Clin Infect Dis; 2006 Dec; 43(12):1562-4. PubMed ID: 17109289
    [No Abstract]   [Full Text] [Related]  

  • 2. Recommended composition of influenza virus vaccines for use in the 2010 influenza season (southern hemisphere winter).
    Wkly Epidemiol Rec; 2009 Oct; 84(41):421-31. PubMed ID: 19817019
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual mutations in the HA1 peptide of amantadine-resistant influenza viruses at positions 193 and 225.
    Inoue Y; Yoneda M; Kitahori Y
    Jpn J Infect Dis; 2007 May; 60(2-3):147-8. PubMed ID: 17515655
    [No Abstract]   [Full Text] [Related]  

  • 4. Adamantane resistance in influenza A.
    Weinstock DM; Zuccotti G
    JAMA; 2006 Feb; 295(8):934-6. PubMed ID: 16493107
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.
    Ison MG; Gubareva LV; Atmar RL; Treanor J; Hayden FG
    J Infect Dis; 2006 Mar; 193(6):760-4. PubMed ID: 16479508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Emergence of amantadine-resistant influenza A viruses].
    Tsuji K; Iwahashi J; Imamura Y; Yoshimoto S; Kajiwara J; Ishibashi T; Mori R; Yamada T; Toyoda T
    Uirusu; 2001 Dec; 51(2):135-41. PubMed ID: 11977753
    [No Abstract]   [Full Text] [Related]  

  • 7. Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.
    Van Poelvoorde LAE; Saelens X; Thomas I; Roosens NH
    Trends Biotechnol; 2020 Apr; 38(4):360-367. PubMed ID: 31810633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.
    Gubareva LV
    Virus Res; 2004 Jul; 103(1-2):199-203. PubMed ID: 15163510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2014 Mar; 89(10):93-104. PubMed ID: 24707514
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommended composition of influenza virus vaccines for use in the 2015–2016 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2015 Mar; 90(11):97-108. PubMed ID: 25771542
    [No Abstract]   [Full Text] [Related]  

  • 12. Antivirals targeting influenza A virus.
    Das K
    J Med Chem; 2012 Jul; 55(14):6263-77. PubMed ID: 22612288
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
    Ferraris O; Lina B
    J Clin Virol; 2008 Jan; 41(1):13-9. PubMed ID: 18055254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to anti-influenza agents.
    Guan Y; Chen H
    Lancet; 2005 Oct; 366(9492):1139-40. PubMed ID: 16198748
    [No Abstract]   [Full Text] [Related]  

  • 15. The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.
    Phillips AM; Shoulders MD
    J Mol Biol; 2016 Feb; 428(3):533-537. PubMed ID: 26748011
    [No Abstract]   [Full Text] [Related]  

  • 16. Implications of antiviral resistance of influenza viruses.
    Monto AS
    Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
    [No Abstract]   [Full Text] [Related]  

  • 17. Published sequences do not support transfer of oseltamivir resistance mutations from avian to human influenza A virus strains.
    Norberg P; Lindh M; Olofsson S
    BMC Infect Dis; 2015 Mar; 15():162. PubMed ID: 25887656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
    Schmidtke M; Bauer K; Ludwig N; Wutzler P
    Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
    [No Abstract]   [Full Text] [Related]  

  • 19. CASCIRE surveillance network and work on avian influenza viruses.
    Bi Y; Shi W; Chen J; Chen Q; Ma Z; Wong G; Tian W; Yin R; Fu G; Yang Y; Liu WJ; Quan C; Wang Q; He S; Li X; Xia Q; Wang L; Pan Z; Li L; Li H; Xu W; Luo Y; Zeng H; Dai L; Xiao H; Sharshov K; Shestopalov A; Shi Y; Yan J; Li X; Liu Y; Lei F; Liu W; Gao GF
    Sci China Life Sci; 2017 Dec; 60(12):1386-1391. PubMed ID: 29294220
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influenza A, will it keep on mutating?].
    Olea-Jiménez V; Mora-Ordóñez JM; Rodríguez-Díez A; Calbo-Torrecillas F
    Med Intensiva; 2012; 36(1):64. PubMed ID: 22197172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.